eprintid: 98131
rev_number: 3
eprint_status: archive
dir: disk0/00/09/81/31
datestamp: 2026-06-19 06:37:55
lastmod: 2026-06-19 06:37:55
status_changed: 2026-06-19 06:37:55
type: article
metadata_visibility: show
creators_name: Kh. O. Darmanov, Kh. O. Darmanov
title: Current relevance of pharmaceutical economy
ispublished: pub
keywords: Emerging Markets, Developed Markets, Pharmaceutical Companies,  Drugs and Disease, BRICS, MIST
abstract: Emerging markets represent an exceptional opportunity for the pharmaceutical industry. Although a precise definition is not yet available, economists define emerging markets as developing prosperous countries in which investment is expected to result in higher income despite high risks. Qualifying a market as emerging is not merely based on the economic status of the country, but also on several criteria that render the definition applicable to each country.
date: 2024-05-24
official_url: https://universalconference.us/index.php/isirc/article/view/1533
full_text_status: public
publication: INTERNATIONAL SCIENTIFIC INNOVATION RESEARCH CONFERENCE
volume: 1
number: 3
pagerange: 3-5
citation:   Kh. O. Darmanov, Kh. O. Darmanov  (2024) Current relevance of pharmaceutical economy.  INTERNATIONAL SCIENTIFIC INNOVATION RESEARCH CONFERENCE, 1 (3).  pp. 3-5.      
document_url: https://arxiv.universalpublishings.com/id/eprint/98131/1/Kh._O._Darmanov_3-5.pdf